CLIMB BIO, INC.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Net Income | $-59.9M | $-73.9M | $-35.1M | $-45.2M | $-47.5M | $-20.7M |
| Depreciation & Amortization | $97.0K | $0 | — | — | — | — |
| Depreciation | — | — | — | — | — | — |
| Amortization | — | — | — | — | — | — |
| Stock-Based Compensation | $8.1M | $5.6M | $12.8M | $7.0M | $3.7M | $707.0K |
| Net Cash from Operating Activities | $-54.4M | $-15.6M | $-20.6M | $-37.4M | $-36.1M | $-14.1M |
| Investing Activities | ||||||
| Capital Expenditures | $186.0K | $0 | $0 | — | — | — |
| Business Acquisitions | $0 | $4.6M | — | — | — | — |
| Net Cash from Investing Activities | $2.8M | $-121.1M | $69.0M | $34.4M | $-115.0M | $8.1M |
| Financing Activities | ||||||
| Dividends Paid | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-21.0K | $130.7M | $841.0K | $0 | $177.2M | $4.9M |
| Net Change in Cash | $-51.5M | $-5.9M | $49.5M | $-3.3M | $26.4M | $-736.0K |
| Free Cash Flow | $-54.5M | $-15.6M | $-20.6M | — | — | — |